His scientific interests lie mostly in Mycobacterium tuberculosis, Tuberculosis, Drug resistance, Molecular epidemiology and Microbiology. Leen Rigouts frequently studies issues relating to Rifampicin and Mycobacterium tuberculosis. He combines subjects such as Internal medicine, Natural history, Pharmacology and Family medicine with his study of Tuberculosis.
The Drug resistance study which covers rpoB that intersects with Gold standard. His Molecular epidemiology study combines topics in areas such as Ecology, Mycobacterium bovis and Chromosomal region, Locus. His Microbiology research is multidisciplinary, incorporating perspectives in Polymerase chain reaction and Mycobacterium, Bacteria.
Leen Rigouts focuses on Mycobacterium tuberculosis, Tuberculosis, Drug resistance, Microbiology and Rifampicin. As part of one scientific family, Leen Rigouts deals mainly with the area of Mycobacterium tuberculosis, narrowing it down to issues related to the Genetics, and often Mycobacterium ulcerans and Mycobacterium bovis. The study incorporates disciplines such as Internal medicine, Multiple drug resistance, Genotype and Virology in addition to Tuberculosis.
He interconnects Mutation, Antibiotics, Capreomycin and Anti tuberculosis in the investigation of issues within Drug resistance. In his research, 16S ribosomal RNA is intimately related to Mycobacterium, which falls under the overarching field of Microbiology. Leen Rigouts has researched Rifampicin in several fields, including Antibacterial agent, Pediatrics and Isoniazid.
His primary scientific interests are in Mycobacterium tuberculosis, Tuberculosis, Drug resistance, Rifampicin and Mycobacterium tuberculosis complex. Leen Rigouts is studying rpoB, which is a component of Mycobacterium tuberculosis. His Sputum study, which is part of a larger body of work in Tuberculosis, is frequently linked to Transmission, bridging the gap between disciplines.
His study in Drug resistance is interdisciplinary in nature, drawing from both Lineage, Pyrazinamide and Virology. His study in the field of Rifampicin resistant tuberculosis is also linked to topics like World health. His Mycobacterium tuberculosis complex research is multidisciplinary, incorporating elements of Extensively drug-resistant tuberculosis and Multi-drug-resistant tuberculosis.
Leen Rigouts spends much of his time researching Mycobacterium tuberculosis, Drug resistance, Rifampicin, Tuberculosis and Microbiology. His study in Ethionamide, Prothionamide and Mycobacterium tuberculosis complex is carried out as part of his studies in Mycobacterium tuberculosis. His Drug resistance research includes themes of Pyrazinamide, Capreomycin, Moxifloxacin, Genome and Internal medicine.
In his study, Genotype is inextricably linked to rpoB, which falls within the broad field of Rifampicin. His Tuberculosis research incorporates elements of Phenotype, Genetics, Gene and Expanded access. His Microbiology study integrates concerns from other disciplines, such as Mycobacterium leprae, Leprosy, Repetitive Element and Mycobacterium.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
Karine Brudey;Jeffrey R Driscoll;Leen Rigouts;Wolfgang M Prodinger.
BMC Microbiology (2006)
Molecular evidence to support a proposal to reserve the designation Mycobacterium avium subsp. avium for bird-type isolates and 'M. avium subsp. hominissuis' for the human/porcine type of M. avium.
Wouter Mijs;Petra de Haas;Rudi Rossau;Tridia Van der Laan.
International Journal of Systematic and Evolutionary Microbiology (2002)
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Armand Van Deun;Armand Van Deun;Kya J. M. Aung;Valentin Bola;Rossin Lebeke.
Journal of Clinical Microbiology (2013)
Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
A. Van Deun;L. Barrera;I. Bastian;L. Fattorini.
Journal of Clinical Microbiology (2009)
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
Paolo Miotto;Belay Tessema;Elisa Tagliani;Leonid Chindelevitch.
European Respiratory Journal (2017)
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations
Leen Rigouts;Leen Rigouts;Mourad Gumusboga;Willem Bram de Rijk;Elie Nduwamahoro.
Journal of Clinical Microbiology (2013)
High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene
Levan Jugheli;Nino Bzekalava;Pim de Rijk;Krista Fissette.
Antimicrobial Agents and Chemotherapy (2009)
Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia
Isdore C Shamputa;Levan Jugheli;Levan Jugheli;Nikoloz Sadradze;Eve Willery.
Respiratory Research (2006)
Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union.
F Portaels;L Rigouts;I Bastian.
International Journal of Tuberculosis and Lung Disease (1999)
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
Matteo Zignol;Anna S. Dean;Natavan Alikhanova;Sönke Andres.
Lancet Infectious Diseases (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: